Results 211 to 220 of about 43,186 (297)

Vasovagal Syncope With Sinus Arrest Triggered by Venipuncture in a Patient Receiving Multiple Psychotropic Medications: A Case Report. [PDF]

Cureus
Kawauchi A, Nakayama A, Abe Y, Yamazaki Y, Maeda S.   +4 more
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Electrocardiographic Abnormalities in Elderly Patients Receiving Psychotropic Therapy in the Emergency Department: A Retrospective Cohort Study. [PDF]

Life (Basel)
Mazza M, Covino M, Bambini F, Romagnoli E, Biondi-Zoccai G, Fuorlo M, Barone F, Racco S, Simeoni B, Franceschi F, Sani G, Marano G.   +11 more
europepmc   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

Primary care for depression before and during the COVID-19 pandemic: a retrospective pre-post study. [PDF]

BMJ Open
Howard M, Freeman K, Hafid S, Vanstone M, Queenan J, Aubrey-Bassler K, Drummond N, Nicholson K, Mangin D.   +8 more
europepmc   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates. [PDF]

Sci Rep
Isohata H, Miura S, Yamazaki Y, Goto H, Yoshimura Y, Hattori K, Shimaoka T, Sekiguchi K, Nakanishi H, Inada K, Ochiai D.   +10 more
europepmc   +1 more source

Trend Study of Psychotropic Medicine Usage by Individuals with Developmental Disabilities

, 2000
Richard L. Gee
openalex   +1 more source